Pfizer Inc. says it plans to outsource more drug manufacturing, lower costs ahead of generic competition for its blockbuster cholesterol drug, Lipitor, ...
Most importantly, it is bracing for the US patent expiration, possibly by 2010, for Lipitor. The company badly needs new products to offset expected ...
The pharmaceutical giant has downsized dramatically ahead of the patent loss for its cholesterol drug Lipitor. By Aaron Smith, CNNMoney.com staff writer ...
Although the Court of Appeal in The Hague, the Netherlands, ruled last week that Pfizer’s Lipitor enantiomer patent is invalid, the same court decided ...
Most importantly, it is bracing for the US patent expiration, possibly by 2010, for Lipitor. The company badly needs new products to offset expected ...
all 3 news articles
In December 2006, the company lost torcetrapib, the cholesterol drug he was counting on to replace Lipitor, when a clinical trial of that medicine was ...
all 5 news articles
So meet JaaJoe, a new right-wing blogger out to make his bones by going after Pfizer’s Lipitor. In a “three-part series” (of which two are now up) he calls ...
Re lipitor, side effects can cause problems with lipitor. LXR activation in the prevention of stroke was lower with atorvastatin. ...